Literature DB >> 17005376

Comparison of three computer-administered cognitive tasks as putative endophenotypes of schizophrenia.

Jeffrey S Bedwell1, Vidyulata Kamath, Elizabeth Baksh.   

Abstract

It has been repeatedly demonstrated that individuals with schizotypal personality features (SPF) exhibit similar endophenotypic traits as persons with schizophrenia. Less research has compared the relative sensitivity of different endophenotypes in the same sample of individuals with SPF. Fourteen university students with SPF (mean age 20.5+/-1.6; 43% male) and 26 controls (mean age 20.3+/-1.1; 31% male) were defined by the Abbreviated Schizotypal Personality Questionnaire (SPQ-B). All participants reported no known biological relative with schizophrenia. Participants completed three computer-administered cognitive tasks: a 6-min degraded-stimuli A-X Continuous Performance Test (CPT), the Wisconsin Card Sort Test (WCST), and a Span of Apprehension (SOA) task (6- and 12-letter arrays). On the CPT, only omission errors resulted in a statistically significant group difference, U=115.5, p=.05, Cohen's d=0.54 (medium effect size), with the SPF group (mean errors: 3.43+/-3.28) making more omission errors than controls (mean errors: 1.88+/-2.66). Notably, 46% of the controls had no omission errors, compared to 14% of the SPF group. The only SPQ-B factor score to show a statistically significant linear relationship with CPT omission errors was the Cognitive-Perceptual factor (rs=.33, p=.04). Group differences on performance indices from the SOA and WCST did not approach statistical significance. Based on performance from the community-identified schizotypes, results suggest that performance on the CPT may represent a more robust endophenotype of schizophrenia, compared to the SOA and WCST.

Entities:  

Mesh:

Year:  2006        PMID: 17005376     DOI: 10.1016/j.schres.2006.08.002

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  6 in total

1.  Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas.

Authors:  Tilo Kircher; Renate Thienel; Michael Wagner; Martina Reske; Ute Habel; Thilo Kellermann; Ingo Frommann; Sibylle Schwab; Wolfgang Wölwer; Martina von Wilmsdorf; Dieter F Braus; Andrea Schmitt; Alexander Rapp; Tony Stöcker; N Jon Shah; Fritz A Henn; Heinrich Sauer; Wolfgang Gaebel; Wolfgang Maier; Frank Schneider
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-09-19       Impact factor: 5.270

2.  The Schizotypal Personality Questionnaire - Child (SPQ-C): Psychometric properties and relations to behavioral problems with multi-informant ratings.

Authors:  Jianghong Liu; Keri Ka-Yee Wong; Fanghong Dong; Adrian Raine; Catherine Tuvblad
Journal:  Psychiatry Res       Date:  2019-03-06       Impact factor: 3.222

3.  Association of Schizotypy With Dimensions of Cognitive Control: A Meta-Analysis.

Authors:  Maria Steffens; Inga Meyhöfer; Kaja Fassbender; Ulrich Ettinger; Joseph Kambeitz
Journal:  Schizophr Bull       Date:  2018-10-15       Impact factor: 9.306

4.  Impact of schizophrenia-risk gene dysbindin 1 on brain activation in bilateral middle frontal gyrus during a working memory task in healthy individuals.

Authors:  Valentin Markov; Axel Krug; Sören Krach; Andreas Jansen; Thomas Eggermann; Karl Zerres; Tony Stöcker; N Jon Shah; Markus M Nöthen; Jens Treutlein; Marcella Rietschel; Tilo Kircher
Journal:  Hum Brain Mapp       Date:  2010-02       Impact factor: 5.038

Review 5.  Genetics, cognition, and neurobiology of schizotypal personality: a review of the overlap with schizophrenia.

Authors:  Ulrich Ettinger; Inga Meyhöfer; Maria Steffens; Michael Wagner; Nikolaos Koutsouleris
Journal:  Front Psychiatry       Date:  2014-02-21       Impact factor: 4.157

6.  Reverse translation of the rodent 5C-CPT reveals that the impaired attention of people with schizophrenia is similar to scopolamine-induced deficits in mice.

Authors:  J W Young; M A Geyer; A J Rissling; R F Sharp; L T Eyler; G L Asgaard; G A Light
Journal:  Transl Psychiatry       Date:  2013-11-12       Impact factor: 6.222

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.